Labor, Induced
1
Pipeline Programs
5
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
5 companies ranked by most advanced pipeline stage
Human BioSciencesWV - Martinsburg
1 programElective Induction of Labor Decision Support ToolN/A1 trial
Active Trials
HologicMARLBOROUGH, MA
1 programPrediction of Spontaneous Onset of Labor at TermN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
SandozSerelaxin
Human BioSciencesElective Induction of Labor Decision Support Tool
HologicPrediction of Spontaneous Onset of Labor at Term
MedicemOutpatient Dilapan-S
Clinical Trials (4)
Total enrollment: 905 patients across 4 trials
Recombinant Human Relaxin (rhRlx) in Pregnant Women Scheduled for Induction of Labor
Start: Nov 2005Est. completion: Oct 200672 patients
Phase 2Completed
Should I Have an Elective Induction?
Start: Mar 2023Est. completion: Sep 202366 patients
N/ACompleted
Prediction of Spontaneous Onset of Labor at Term
Start: Aug 2019Est. completion: Dec 2022429 patients
N/ACompleted
Comparing Outpatient to Inpatient Cervical Ripening Using Dilapan-S®
Start: Nov 2018Est. completion: Nov 2021338 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
5 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.